How it works

The Calm + Clarity Blend provides layered neuroprotection and anxiolysis through three distinct mechanisms:

PE-22-28 Component: Derived from Prohibitin, this peptide interacts with mitochondrial and nuclear signaling pathways to enhance cellular stress resistance. PHB family proteins regulate mitochondrial morphogenesis, cell cycle progression, and transcriptional control. PE-22-28 enhances neuronal resilience against oxidative stress and metabolic insults at the cellular level.

Pinealon Component (Glu-Asp-Arg): As a Khavinson bioregulator, Pinealon penetrates cells and interacts directly with DNA at the level of histone modification and transcription factor accessibility. It modulates expression of genes involved in melatonin synthesis (AANAT, ASMT), circadian clock regulation, and neuroprotective pathways. Effects persist beyond the dosing period because gene expression changes are sustained through epigenetic mechanisms. Works at very low concentrations through direct DNA interaction rather than classical receptor binding.

Selank Component: Modulates GABA-A receptor sensitivity to enhance inhibitory neurotransmission without benzodiazepine-site binding. Influences serotonin metabolism through tryptophan hydroxylase activity and serotonin transporter dynamics. The tuftsin core provides immunomodulatory activity including enhanced phagocytic function and natural killer cell activity.

Synergy: PE-22-28 provides baseline neuroprotection at the mitochondrial level, Pinealon supports long-term neuronal health through epigenetic gene regulation, and Selank provides real-time anxiolytic calming. Together they create a multi-layered neuroprotective environment that supports both acute cognitive performance and long-term brain health.

02

What to expect

Early

Days 1–7

Days 1-7: Selank anxiolytic calming typically felt within 1-2 doses. Reduced anxiety and improved emotional regulation without sedation. PE-22-28 neuroprotective effects begin at the cellular level but are not subjectively noticeable this early. Pinealon begins gene expression modulation in pineal tissue. Mild injection site effects possible.

Mid

Weeks 2–4

Weeks 2-4: Selank effects are well-established with consistent calm focus. Pinealon melatonin support may improve sleep onset and circadian consistency. PE-22-28 cellular stress resistance building cumulatively. Users often report a sustained sense of mental equilibrium and resilience to stress.

Later

Weeks 4–12

Weeks 4-12: Full benefits of the neuroprotective trio realized. Pinealon epigenetic changes become self-sustaining (effects persist after discontinuation). PE-22-28 cellular protection at maximum. Selank GABA modulation stable. Note that Pinealon as a bioregulator may benefit from course-style dosing (10-20 days) with extended rest periods, as its gene expression effects persist for months.

03

Evidence

HumanNo published trials

AnimalPresent

In-vitroPresent

2008Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia · Zozulya AA et al, Zhurnal Nevrologii i Psikhiatrii ↗peer reviewed

2017GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells · Volkova A et al, Frontiers in Pharmacology ↗peer reviewed

2012Pinealon protects the rat offspring from prenatal hyperhomocysteinemia · Arutjunyan A et al, International Journal of Clinical and Experimental Medicine ↗peer reviewed

2021EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease · Khavinson V et al, International Journal of Molecular Sciences ↗peer reviewed

04

The honest take

◆

Broadest peptide compatibility of any commercial blend

Unproven in humans

Supported by chemistry. None of the three components contain methionine, tryptophan, cysteine, or histidine residues, eliminating oxidation concerns with GHK-Cu. No anionic charge issues means compatibility with LL-37. This is a verifiable chemical property, not a clinical claim.

Pinealon effects persist for weeks to months through epigenetic mechanisms

Partly true

Partially supported. In vitro data confirms Pinealon interacts with DNA and modifies gene expression. The persistence of epigenetic changes beyond dosing is consistent with bioregulator theory and some animal data, but human duration-of-effect studies with modern methodology are lacking.

PE-22-28 enhances cellular stress resistance through mitochondrial signaling

Unproven in humans

Supported by preclinical data only. PE-22-28 is derived from Prohibitin, a well-characterized mitochondrial protein. Cellular and animal studies show neuroprotective effects. No human data exists to confirm these effects translate to clinical benefit.

05

Interactions & stacking

What's safe to combine, and what belongs in a separate pin.

Safe & synergistic

GHK-CuNo Met, Trp, Cys, or His in any component. FULLY compatible for co-storage and syringe mixing. No oxidation concern whatsoever. Draw GHK-Cu LAST per standard protocol.

LL-37No anionic charge issues in any component. FULLY compatible. This is one of the few blends that can safely mix with LL-37.

IpamorelinGH secretagogue. No residue conflicts. Safe in same syringe.

CJC-1295 no DAC / Ipamorelin BlendGH axis stimulation. No residue conflicts. Safe in same syringe.

Keep separate

CJC-1295 with DACDAC maleimide linker may react with peptides in syringe. Pin CJC-DAC separately.

NAD+Acidic pH can denature peptide components. Pin separately.

GlutathioneThiol chemistry may interfere with peptide stability. Pin separately.

06

Side effects & safety

Commonly reported

Mild injection site redness or warmth
Occasional brief drowsiness from Selank (paradoxical in some users)
Subtle shifts in sleep timing as circadian rhythms adjust

Less common & notes

Rarely reported: mild headache, transient nausea.
PE-22-28 has limited human safety data as a newer research compound.
Selank is an approved medication in Russia with established safety.
Pinealon is a bioregulator with decades of Russian clinical use.
Long-term safety data for this specific combination does not exist.

07

Pharmacokinetics

Illustrative plasma concentration · 24 h

Half-life

PE-22-28: ~2 hours; Pinealon: ~30 min; Selank: ~30 min

Peak · Tmax

PE-22-28: ~30 min; Pinealon: ~3 min; Selank: ~45 min

Elimination

PE-22-28: ~10 hours; Pinealon: ~2.5 hours; Selank: ~2.5 hours

Activity

PE-22-28: 12-24 hours (cellular stress resistance signaling); Pinealon: weeks to months (epigenetic gene expression changes persist beyond dosing); Selank: 6-12 hours (GABA/serotonin modulation)

Storage. Reconstitute with bacteriostatic water. Store refrigerated at 2-8 degrees C. Shelf life approximately 28 days after reconstitution. This blend has good stability due to the absence of oxidation-sensitive residues (no Met, Trp, Cys, His). Do not freeze after reconstitution. Protect from light. Discard if cloudy or particulate matter visible.

08

Regulatory status

Not FDA-approved. Selank is an approved prescription medication in Russia. PE-22-28 and Pinealon are classified as research peptides. Pinealon has decades of use in Russian bioregulator medicine. Available through compounding pharmacies and research suppliers. All use of this blend is experimental and off-label outside Russia.

Calm + Clarity Blend